BioGaia Sees US Investments Paying Off As Q1 Sales Rise

Sweden's BioGaia is looking to capitalize on growing momentum in the US probiotics market with a number of launches. The firm's recent US growth helped to offset falling sales in its more established European markets during the first quarter.